OptimizeRx Corp. (OPRX), a healthcare technology company, Monday announced it has appointed Steve Silvestro as Chief Executive Officer, with effect from March 10. He has been serving as President and interim CEO.
Silvestro has over 20 years of experience in health technology and services. Silvestro joined the company in 2019.
Friday, OptimizeRx had closed at $4.58, down 2.97 percent on the Nasdaq.
For comments and feedback: editorial@rttnews.com